Neurogait is developing home diagnostic solutions for Alzheimers disease, Parkinsons disease, and other neurodegenerative diseases using various biological markers.

The company seeks to democratize and standardize the diagnostic process and to provide early diagnosis prior to onset so that treatment can be provided and mitigated before disease is manifested.Neurogait leverages the latest research in machine learning, computer vision, voice recognition, and additional technologies to accurately diagnose and improve current standards of care.

The company is currently running clinical trials in leading Israeli hospitals.